Cargando…
Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
Basal cell carcinoma (BCC) is the most common skin cancer. It generally has an indolent course with low rates of metastasis and mortality. However, BCC is locally invasive and can cause significant morbidity due to destructive local spread. We report our experience with a patient who was referred to...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
São Paulo, SP: Universidade de São Paulo, Hospital Universitário
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771444/ https://www.ncbi.nlm.nih.gov/pubmed/31641658 http://dx.doi.org/10.4322/acr.2019.116 |